• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁螯合剂作为治疗阿尔茨海默病和帕金森病的潜在治疗药物的研究进展。

A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.

机构信息

Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (Banaras Hindu University), Varanasi, 221005, India.

出版信息

Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.

DOI:10.1007/s11030-018-9878-4
PMID:30293116
Abstract

Iron plays a vital role in several cellular functions due to its unique physiochemical properties. Iron concentration increases in the brain with age due to multiple factors. Excessive amount of iron can lead to formation of reactive oxygen species. Neurodegenerative disorders are characterized by iron supplemented increase in oxidative stress and cellular damage. There is an urgent need of novel therapies which should not only provide symptomatic relief but also be able to modulate iron accumulation in the brain. Therefore, the development of novel iron chelators as neuroprotective agents for the treatment of neurodegeneration is an emerging trend. Several iron chelators including 8-hydroxyquinoline derivatives, dopaminergic agonists and natural products are under preclinical and clinical investigations for the treatment of neurodegenerative disorders.

摘要

铁因其独特的物理化学性质,在多种细胞功能中起着至关重要的作用。由于多种因素,铁浓度会随着年龄的增长在大脑中增加。过多的铁会导致活性氧的形成。神经退行性疾病的特征是铁补充增加氧化应激和细胞损伤。因此,我们急需新的治疗方法,这些方法不仅要能提供症状缓解,还要能够调节大脑中的铁积累。因此,开发新型铁螯合剂作为神经保护剂来治疗神经退行性疾病是一种新兴趋势。几种铁螯合剂,包括 8-羟基喹啉衍生物、多巴胺激动剂和天然产物,正在进行临床前和临床研究,以治疗神经退行性疾病。

相似文献

1
A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer's and Parkinson's diseases.铁螯合剂作为治疗阿尔茨海默病和帕金森病的潜在治疗药物的研究进展。
Mol Divers. 2019 May;23(2):509-526. doi: 10.1007/s11030-018-9878-4. Epub 2018 Oct 6.
2
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.新型双功能药物靶向单胺氧化酶抑制和铁螯合,作为帕金森病及其他神经退行性疾病神经保护的一种方法。
J Neural Transm (Vienna). 2004 Oct;111(10-11):1455-71. doi: 10.1007/s00702-004-0143-x. Epub 2004 Apr 20.
3
The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders.铁螯合剂在帕金森病及相关神经疾病治疗中的潜在作用。
Pharmacol Toxicol. 1997 Apr;80(4):159-66. doi: 10.1111/j.1600-0773.1997.tb00390.x.
4
Neurodegenerative diseases and therapeutic strategies using iron chelators.神经退行性疾病与使用铁螯合剂的治疗策略
J Trace Elem Med Biol. 2015;31:267-73. doi: 10.1016/j.jtemb.2014.12.012. Epub 2015 Jan 22.
5
Iron in neurodegenerative disorders: being in the wrong place at the wrong time?神经退行性疾病中的铁:在错误的时间出现在错误的地点?
Rev Neurosci. 2017 Nov 27;28(8):893-911. doi: 10.1515/revneuro-2017-0020.
6
Iron and Parkinson's disease: chelators to the rescue?铁与帕金森病:螯合剂能否挽救?
Nutr Rev. 2003 Sep;61(9):311-3. doi: 10.1301/nr.2003.sept.311-313.
7
Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.使用铁螯合剂消除帕金森病和其他神经退行性疾病中的铁:来自6-羟基多巴胺与铁螯合剂、去铁胺和VK-28的启示。
Ann N Y Acad Sci. 2004 Mar;1012:306-25. doi: 10.1196/annals.1306.025.
8
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.趁热打铁:神经退行性变中的铁代谢和铁死亡。
Free Radic Biol Med. 2019 Mar;133:221-233. doi: 10.1016/j.freeradbiomed.2018.09.033. Epub 2018 Sep 25.
9
Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.新型双功能铁螯合剂的设计、合成与评价:作为阿尔茨海默病、帕金森病及其他神经退行性疾病神经保护潜在药物的研究
Bioorg Med Chem. 2005 Feb 1;13(3):773-83. doi: 10.1016/j.bmc.2004.10.037.
10
Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators.使用多模式神经保护和神经修复性铁螯合剂针对多种阿尔茨海默病病因
FASEB J. 2008 May;22(5):1296-305. doi: 10.1096/fj.07-8627rev. Epub 2007 Nov 29.

引用本文的文献

1
From Tradition to Innovation: Acupuncture Therapies Targeting Ferroptosis in Neurological Disorders.从传统到创新:针对神经疾病中铁死亡的针灸疗法
Brain Behav. 2025 Sep;15(9):e70827. doi: 10.1002/brb3.70827.
2
Discovery of Selective β-Secretase (BACE-1) Inhibitors by the Solid-Phase Synthesis of Small Molecular-sized Peptides.通过小分子肽的固相合成发现选择性β-分泌酶(BACE-1)抑制剂
Curr Alzheimer Res. 2024;21(10):723-734. doi: 10.2174/0115672050336253241227102506.
3
Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.

本文引用的文献

1
The Aging of Iron Man.钢铁侠的衰老
Front Aging Neurosci. 2018 Mar 12;10:65. doi: 10.3389/fnagi.2018.00065. eCollection 2018.
2
Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.哌嗪二酮作为治疗阿尔茨海默病的双重抑制剂的研发
Eur J Med Chem. 2018 Apr 25;150:87-101. doi: 10.1016/j.ejmech.2018.02.078. Epub 2018 Feb 27.
3
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.β-分泌酶抑制剂治疗阿尔茨海默病:前路漫漫。
帕金森病中的缺氧途径:从发病机制到治疗靶点。
Int J Mol Sci. 2024 Sep 29;25(19):10484. doi: 10.3390/ijms251910484.
4
Gold Nanoparticles in Parkinson's Disease Therapy: A Focus on Plant-Based Green Synthesis.帕金森病治疗中的金纳米颗粒:聚焦基于植物的绿色合成
Cureus. 2024 Feb 22;16(2):e54671. doi: 10.7759/cureus.54671. eCollection 2024 Feb.
5
The Role of Iron Metabolism in Sepsis-associated Encephalopathy: a Potential Target.铁代谢在脓毒症相关性脑病中的作用:一个潜在的靶点。
Mol Neurobiol. 2024 Jul;61(7):4677-4690. doi: 10.1007/s12035-023-03870-2. Epub 2023 Dec 19.
6
Interplay between microglia and environmental risk factors in Alzheimer's disease.阿尔茨海默病中,小胶质细胞与环境风险因素之间的相互作用。
Neural Regen Res. 2024 Aug 1;19(8):1718-1727. doi: 10.4103/1673-5374.389745. Epub 2023 Dec 11.
7
Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation.DJ-1 功能缺失通过 RACK1 介导的 PKC 激活和 MAO-B 上调导致小鼠帕金森病发病机制。
Acta Pharmacol Sin. 2023 Oct;44(10):1948-1961. doi: 10.1038/s41401-023-01104-8. Epub 2023 May 25.
8
Gut Dysbiosis: A Target for Protective Interventions against Parkinson's Disease.肠道微生物群失调:帕金森病保护性干预的靶点
Microorganisms. 2023 Mar 29;11(4):880. doi: 10.3390/microorganisms11040880.
9
The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer's Disease: from the Perspective of Ferroptosis.铁代谢、脂质代谢和氧化还原稳态在阿尔茨海默病中的作用:从铁死亡角度探讨
Mol Neurobiol. 2023 May;60(5):2832-2850. doi: 10.1007/s12035-023-03245-7. Epub 2023 Feb 3.
10
Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.金属螯合疗法在微量元素超负荷诱导的阿尔茨海默病中的挑战与机遇。
Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.
Eur J Med Chem. 2018 Mar 25;148:436-452. doi: 10.1016/j.ejmech.2018.02.035. Epub 2018 Feb 15.
4
Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigra.转铁蛋白可预防帕金森病神经毒性,并在帕金森病黑质中缺乏。
Signal Transduct Target Ther. 2016 Sep 2;1:16015. doi: 10.1038/sigtrans.2016.15. eCollection 2016.
5
Silibinin: an old drug for hematological disorders.水飞蓟宾:一种用于血液系统疾病的老药。
Oncotarget. 2017 Jul 11;8(51):89307-89314. doi: 10.18632/oncotarget.19153. eCollection 2017 Oct 24.
6
Cortical Iron Reflects Severity of Alzheimer's Disease.皮质铁反映阿尔茨海默病的严重程度。
J Alzheimers Dis. 2017;60(4):1533-1545. doi: 10.3233/JAD-161143.
7
Amino- and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents.氨基和氯代8-羟基喹啉及其铜配合物作为蛋白酶体抑制剂和抗增殖剂。
Metallomics. 2017 Oct 18;9(10):1439-1446. doi: 10.1039/c7mt00156h.
8
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.新型化合物 PBT434 可预防多种帕金森病模型中铁介导的神经退行性变和α-突触核蛋白毒性。
Acta Neuropathol Commun. 2017 Jun 28;5(1):53. doi: 10.1186/s40478-017-0456-2.
9
α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease.α-突触核蛋白聚集调节:一种新兴的帕金森病治疗方法。
Future Med Chem. 2017 Jun;9(10):1039-1053. doi: 10.4155/fmc-2017-0016. Epub 2017 Jun 20.
10
Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.水飞蓟宾抑制 Aβ 淀粉样肽的生长和毒性:立体化学的关键作用。
ACS Chem Neurosci. 2017 Aug 16;8(8):1767-1778. doi: 10.1021/acschemneuro.7b00110. Epub 2017 Jun 9.